COCH
Envoy Medical Inc.
0.678$
+2.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,373.8% | -11,731.6% | -9,908.5% | -6,832.4% | -5,012.5% | -10,447.6% | -8,097.8% | -5,717.9% | -10,311.9% | -7,580.0% | -15,541.0% | -10,698.0% | -10,402.4% | |
| 36.3% | 50.5% | 57.6% | 61.8% | 87.5% | 114.3% | 132.6% | 109.0% | 181.0% | 106.7% | 187.2% | 145.1% | 146.4% | |
| 0.0% | 1,657.9% | 208.5% | 208.8% | 257.1% | 364.3% | 347.8% | 187.2% | 771.4% | -85.3% | 112.8% | 568.6% | 287.0% | |
| 5,892.5% | -7,171.6% | -2,015.3% | 335.3% | 2,067.9% | -2,404.8% | 2,004.3% | 98.7% | 1,814.3% | 104.0% | -1,943.6% | -1,331.4% | -288.4% | |
| 77.5% | 22.1% | 184.7% | 1,161.8% | 1,098.2% | 1,271.4% | 13.0% | 1.3% | 0.0% | 229.3% | 0.0% | 11.8% | 86.0% | |
| -77.5% | -22.1% | -184.7% | -1,161.8% | -1,098.2% | 1,271.4% | -13.0% | -1.3% | – | -229.3% | – | -11.8% | – | |
| – | – | – | 0.0% | 3,273.2% | 1,461.9% | 2,637.0% | 778.2% | 0.0% | 1.3% | 3,461.5% | 2,529.4% | 1,275.8% | |
| 484,508.5% | – | – | – | – | 150.0% | – | 98.7% | – | 142.7% | – | 203.9% | – | |
| – | – | – | – | 13,064.3% | 9,723.8% | 10,363.0% | 6,107.7% | -635.7% | -121.3% | -533.3% | -417.6% | -376.3% | |
| 19,670.0% | -1,530.5% | 11,327.1% | 3,291.2% | 10,894.6% | 11,700.0% | 7,726.1% | 5,689.7% | 6,192.9% | 8,053.3% | 70,702.6% | -213.7% | 17,442.5% | |
| 20,965.0% | -13,286.3% | 1,232.2% | -4,704.4% | 4,782.1% | 2,521.4% | -371.7% | -32.1% | -4,121.4% | 244.0% | 55,159.0% | -10,925.5% | 6,952.7% | |
| 1,296.3% | -11,753.7% | -10,093.2% | -7,994.1% | -6,110.7% | -9,176.2% | -8,110.9% | -5,719.2% | -10,311.9% | -7,809.3% | -15,541.0% | -10,709.8% | -10,488.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.